Recruiting
Small cell lung cancer+2
RecruitingStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
Registered drugNo placebo
Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
Registered drugNo placebo
- Disease:Small cell lung cancerSmall cell lung cancer extensive stage+1
- Substances:AtezolizumabBNT327+3
Countries:
Romania
Romania- Participants:18–64 years · 65+ years
- Substances:Atezolizumab
- Sponsor:BioNTech SE



